Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

Preceptorship on MRI in multiple sclerosis

PART OF MS Alumni FEATURE
Preceptorship on MRI in multiple sclerosis
  • Neurology
  • Multiple sclerosis
Preceptorship by Excemed
Thursday, Oct 30 - Friday, Oct 31 2014
Milan, Italy

Accreditation

EACCME®

Event format

Lecture
Registration status
Closed

Overview

MRI techniques are essential to making a diagnosis of multiple sclerosis (MS) especially at the very early stages of the disease. Moreover, in the everyday  clinical  setting  MR  markers  are  more  and  more  crucial  for treatment  choice  and  monitoring.  Innovative  imaging  techniques  are now available enabling new insights into the pathogenesis of MS and its functional consequences. In this context, specific training is mandatory to analyse and interpret MRI findings. The live educational preceptorship will provide participants with lectures given by world renowned experts in MR  in  MS  and  hands-on  training,  held  at  the Neuroimaging and Neuroimmunology Research Unit.

Learning objectives

By attending this live educational course participants will be able to:

  • Apply MR diagnostic criteria for diagnosing MS
  • Distinguish and rule out clinical conditions that can mimic MS at the MR scan
  • Summarise the novel functional and structural markers of disease severity obtained by advanced MRI techniques
  • Interpret MRI scans and estimate other relevant imaging outcomes

Accreditation details

EXCEMED (www.excemed.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide  the  following  CME  activity  for  medical  specialists.  The  EACCME ® is  an  institution  of  the  European  Union  of  Medical Specialists (UEMS), www.uems.net

The CME Preceptorship on MRI in multiple sclerosis to be held on 30-31 October 2014 in Milan, Italy, is designated for a maximum of 10 (ten) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she  actually  spent  in  the  educational  activity.  EACCME® credits  are  recognized  by  the  American  Medical  Association  (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.

 

EXCEMED adheres to the principles of the Good CME Practice Group (gCMEp).

MS Alumni

The MS Alumni programme is an educational initiative of EXCEMED that is intended to provide ongoing support for young physicians and specialists in neurology.

Scientific programme

Thursday, 30 October

09.30 L1: The clinical work up of patients suspected of having MS

P.S. Sørensen (Denmark)

10.00 L2: Individualized treatment in patients with MS

G. Comi (Italy)

10.30 L3: Future MR markers to monitor MS

N. De Stefano (Italy)

11.30 L4: The MRI criteria for diagnosing MS

J. Sastre-Garriga (Spain)

12.00 L5: MRI and the differential diagnosis in patients suspected of having MS

A. Falini (Italy)

13.45 CS1: Case studies on diagnosis/differential diagnosis

There  will  be  two  case  study  sessions  and different cases will be presented and discussed.  These  sessions  will  involve  attendees  in  an interactive discussion, giving them the chance to share opinions and understanding of different MS related topics.

S. Gerevini (Italy)

Friday, 31 October

09.00 L6: Understanding MS evolution using structural MR techniques

M.M. Schoonheim (The Netherlands)

09.30 L7: Understanding MS evolution using functional MR techniques

M.A. Rocca (Italy)

10.00 L8: Optic nerve MRI

D. Chard (UK)

10.30 L9: Spinal cord MRI

P. Valsasina (Italy)

11.30 L10: MRI and cognition

F. Agosta (Italy)

12.00 L11: MRI and clinical trials

G. Edan (France)

12.30 L12: The role of imaging techniques in clinical neurology

M. Filippi (Italy)

14.10 CS2: Case studies on treatment decision making: the role of MRI

M.A. Rocca (Italy)

Chair(s)

Massimo Filippi

Division of Neuroscience
San Raffaele Scientific Institute
Vita-Salute San Raffaele University
Milano, Italy

Faculty

Disclosure of Faculty Relationships

 

EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME ® ) and all other professional organizations, as applicable, which state that programmes awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products  (other  than  those  uses  indicated  in  approved  product  labeling/package  insert  for  the  product)  may  be  presented  in  the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and all programme-related materials neither imply an endorsement nor a recommendation on the part of EXCEMED. All presentations represent solely the independent views of the presenters/authors.

The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-EMEA/FDA approved (off-label) uses of drugs:

Federica Agosta Declared no potential conflict of interest.

Declan Chard Declared receipt of honoraria or consultation fees from Teva, Bayer. He declared to be in the advisory boards of Teva.

Giancarlo Comi Declared receipt of honoraria or consultation fees from Novartis, Teva, Sanofi, Genzyme, Merck, Biogen, Bayer, Almirall.

Nicola De Stefano Declared receipt of honoraria or consultation fees from: Novartis, Merck Serono, Biogen Idec, Teva, Sanofi Aventis. He declared to be member of a company sponsored speakers' bureau: Novartis, Merck Serono, Biogen Idec, Teva, Bayer, Sanofi Aventis. He declared also to be member of a company advisory board, board of directors or other similar groups: Novartis, Merck Serono, Biogen Idec.

Gilles Edan Declared receipt of grants and contracts from Merck Serono, Teva and Novartis. He declared receipt of honoraria or consultation fees from Merck Serono, Teva, Biogen Idec, Novartis. He declared to be member of accompany advisory board, board of directors or other similar groups: LFB.

Andrea Falini Declared no potential conflict of interest.

Massimo Filippi Declared receipt of grants and contracts from Bayer, Biogen, Genmab, Novartis, Merck Serono, Teva. He declared receipt of honoraria or consultation fees from Bayer, Biogen, Genmab, Novartis, Merck Serono, Teva. He is a member of company sponsored speaker’s bureau: Bayer, Biogen, Genmab, Merck Serono, Teva. He declared to be member of accompany advisory board, board of directors or other similar groups: Teva and Genmab.

Simonetta Gerevini Declared participation in a company sponsored speaker’s bureau: Biogen Idec.

Maria Assunta Rocca Declared receipt of grants and contracts from Italian Ministry of Health and FISM. She declared participation in a company sponsored speaker’s bureau: Biogen Idec, Merck Serono, Novartis.

Jaume Sastre-Garriga Declared receipt of honoraria or consultation fees from Almirall, Biogen, Novartis. He declared participation in a company sponsored speaker’s bureau: Teva, Merck Serono, Genzyme.

Menno M. Schoonheim Declared no potential conflict of interest.

Per Soelberg Sørensen Declared to be member of scientific advisory boards: Biogen Idec, Merck Serono, Novartis, Genmab, TEVA, GSK; has been on steering committees or independent data monitoring boards in clinical trials sponsored by Merck Serono, Genmab, TEVA, GSK. He declared reception of honoraria or consultation fees from: Biogen Idec, Merck Serono, TEVA, Bayer Schering, Sanofi-aventis, Genzyme, and Novartis.

Paola Valsasina Declared no potential conflict of interest.

Article
Neurology
Slide kit
Giancarlo Comi
Neurology
Slide kit
Gilles Edan
Neurology
Slide kit
Simonetta Gerevini
Neurology
Article
Lucia Moiola
Neurology
Slide kit
Maria Assunta Rocca
Neurology
Article
Maria Assunta Rocca
Neurology
Article
Maria Assunta Rocca
Neurology
Slide kit
Jaume Sastre Garriga
Neurology
Slide kit
Per Soelberg Sørensen
Neurology
Paola Valasina
Neurology
Slide kit
Paola Valasina
Neurology